Compare JD Health International, Inc. with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
- The company is Net-Debt Free
2
Risky -
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.64%
0%
1.64%
6 Months
17.77%
0%
17.77%
1 Year
42.21%
0%
42.21%
2 Years
-29.31%
0%
-29.31%
3 Years
-35.17%
0%
-35.17%
4 Years
-66.37%
0%
-66.37%
5 Years
0%
0%
0.0%
JD Health International, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
25.17%
EBIT Growth (5y)
12.09%
EBIT to Interest (avg)
-5.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.58
EV to EBIT
-28019.75
EV to EBITDA
-32911.25
EV to Capital Employed
3.85
EV to Sales
3339.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.01%
ROE (Latest)
-0.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
79,649.00
63,058.30
26.31%
Operating Profit (PBDIT) excl Other Income
4,422.70
1,493.60
196.11%
Interest
12.00
8.90
34.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,820.80
4,507.10
29.15%
Operating Profit Margin (Excl OI)
51.70%
20.00%
3.17%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 26.31% vs 6.61% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 29.15% vs 90.34% in Dec 2024
About JD Health International, Inc. 
JD Health International, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






